SCPH - Scpharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SCPH is currently covered by 4 analysts with an average price target of $15.29. This is a potential upside of $11.09 (264.05%) from yesterday's end of day stock price of $4.2.

Scpharmaceuticals's activity chart (see below) currently has 10 price targets and 23 ratings on display. The stock rating distribution of SCPH is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for SCPH is $18, Lowest price target is $12, average price target is $14.33.

Most recent stock forecast was given by NAZ RAHMAN from MAXIM GROUP on 20-Mar-2025. First documented stock forecast 15-Oct-2019.

Best performing analysts who are covering SCPH - Scpharmaceuticals:

Naz Rahman Glen Santangelo Douglas Tsao

Currently out of the existing stock ratings of SCPH, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$7.8 (185.71%)

$20

2 months 19 days ago
(20-Mar-2025)

0/3 (0%)

$8.99 (298.67%)

Buy

$18

$13.8 (328.57%)

$18

2 months 19 days ago
(20-Mar-2025)

0/12 (0%)

$14.99 (498.01%)

Buy

$13

$8.8 (209.52%)

$16

6 months 6 days ago
(02-Dec-2024)

0/3 (0%)

$9.29 (250.40%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SCPH (Scpharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on SCPH (Scpharmaceuticals) with a proven track record?

NAZ RAHMAN

Which analyst has the current lower performing score on SCPH (Scpharmaceuticals) with a proven track record?

DOUGLAS TSAO

Which analyst has the most public recommendations on SCPH (Scpharmaceuticals)?

Naz Rahman works at MAXIM GROUP and has 2 price targets and 2 ratings on SCPH

Which analyst is the currently most bullish on SCPH (Scpharmaceuticals)?

Douglas Tsao with highest potential upside - $13.8

Which analyst is the currently most reserved on SCPH (Scpharmaceuticals)?

Naz Rahman with lowest potential downside - $7.8

Scpharmaceuticals in the News

scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences

BURLINGTON, Mass., May 01, 2025 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that John Tucker, President and Chief Executive Officer, will participate in the following upcoming investor conferences: The Citizens Life Sciences Conference: Presentation on Wednesday, May 7 at 9:30...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?